{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T15:48:00Z","timestamp":1715528880214},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1983]]},"DOI":"10.1007\/bf00607081","type":"journal-article","created":{"date-parts":[[2004,11,24]],"date-time":"2004-11-24T13:39:43Z","timestamp":1101303583000},"page":"747-750","source":"Crossref","is-referenced-by-count":0,"title":["Sulphinpyrazone and renal function following myocardial infarction"],"prefix":"10.1007","volume":"24","author":[{"given":"S. L.","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wieringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. B.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"818","volume":"92","author":"HA Smythe","year":"1965","unstructured":"Smythe HA, Ogryzlu MA, Murphy EA, Mustard JF (1965) The effect of sulphinpyrazone (Anturan) on platelet economy and blood coagulation in man. Can Med Assoc J 92: 818?821","journal-title":"Can Med Assoc J"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM198001313020502","volume":"302","author":"The Anturan Reinfarction Trial Research Group","year":"1980","unstructured":"The Anturan Reinfarction Trial Research Group (1980) Sulphinpyrazone in the prevention of sudden death after myocardial infarction. N Engl J Med 302: 250?256","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM198001313020510","volume":"302","author":"E Braunwald","year":"1980","unstructured":"Braunwald E (1980) Treatment of the patient after myocardial infarction. N Engl J Med 302: 290?293","journal-title":"N Engl J Med"},{"key":"CR4","first-page":"237","volume":"1","author":"Anturan Reinfarction Italian Study Group","year":"1982","unstructured":"Anturan Reinfarction Italian Study Group (1982) Sulphinpyrazone in postmyocardial infarction. Lancet 1: 237?42","journal-title":"Lancet"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM198012183032534","volume":"303","author":"R Temple","year":"1980","unstructured":"Temple R, Pledger GW (1980) The F.D.A. critique of the Anturane Reinfarction Trial. N Engl J Med 303: 1488?1491","journal-title":"N Engl J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/bmj.1.6173.1242","volume":"1","author":"CTG Flear","year":"1979","unstructured":"Flear CTG, Hilton P (1979) Hyponatraemia and severity and outcome of myocardial infarction. Br Med J 1: 1242?1246","journal-title":"Br Med J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/archinte.1976.03630090082020","volume":"163","author":"J Braun","year":"1976","unstructured":"Braun J (1976) Abnormalities of urinary sediment and renal failure following sulphinpyrazone therapy. Arch Intern Med 163: 1060?1061","journal-title":"Arch Intern Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bmj.282.6264.609","volume":"282","author":"DS Durham","year":"1981","unstructured":"Durham DS, Ibels LS (1981) Sulphinpyrazone induced acute renal failure. Br Med J 282: 609","journal-title":"Br Med J"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.281.6239.531","volume":"281","author":"RG Wilcox","year":"1980","unstructured":"Wilcox RG, Richardson D, Hampton JR, Mitchell JRA, Banks DC (1980) Sulphinpyrazone in acute myocardial infarction: Studies on cardiac rhythm and renal function. Br Med J 281: 531?534","journal-title":"Br Med J"},{"key":"CR10","unstructured":"W.H.O. (1971) Ischaemic Heart Register, Copenhagen"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/clinchem\/25.7.1317","volume":"25","author":"J Iwata","year":"1979","unstructured":"Iwata J, Nishinkage O (1979) New micro turbidimetric method for determination of protein in cerebrospinal fluid and urine. Clin Chem 25: 1317?1319","journal-title":"Clin Chem"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0009-8981(75)90245-4","volume":"62","author":"SM Tucker","year":"1975","unstructured":"Tucker SM, Boyd PJR, Thompson AE, Price RG (1975) Automated assay of N-acetyl-?-glucosaminidase in normal and pathological human urine. Clin Chim Acta 62: 333?339","journal-title":"Clin Chim Acta"},{"key":"CR13","first-page":"251","volume":"33","author":"JJ Fleming","year":"1980","unstructured":"Fleming JJ, Child JA, Cooper EH, Hay AM, Morgan DB, Parapia L (1980) Renal tubular damage without glomerular damage after cytotoxic drugs and amino-glycosides. Biomed 33: 251?254","journal-title":"Biomed"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7326\/0003-4819-34-6-1421","volume":"34","author":"MM Gertler","year":"1951","unstructured":"Gertler MM, Garn SM, Levine SA (1951) Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 34: 1421?1431","journal-title":"Ann Intern Med"},{"key":"CR15","first-page":"367","volume":"46","author":"D Jacobs","year":"1972","unstructured":"Jacobs D (1972) Hyperuricaemia and myocardial infarction. S Afr Med J 46: 367?369","journal-title":"S Afr Med J"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5694\/j.1326-5377.1974.tb93174.x","volume":"1","author":"R McEwin","year":"1974","unstructured":"McEwin R, McEwin K, Loudon B (1974) Raised serum uric acid levels with myocardial infarction. Med J Aust 1: 530?532","journal-title":"Med J Aust"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00607081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00607081\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00607081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T08:23:07Z","timestamp":1585988587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00607081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1983]]}},"alternative-id":["BF00607081"],"URL":"https:\/\/doi.org\/10.1007\/bf00607081","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983]]}}}